Bar Harbor Trust Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-231,134
Closed -$12.8M 89
2022
Q1
$12.8M Buy
231,134
+864
+0.4% +$44.3K 3.87% 2
2021
Q4
$12.9M Sell
230,270
-6
-0% -$325 3.45% 4
2021
Q3
$11.1M Sell
230,276
-4,348
-2% -$210K 3.45% 3
2021
Q2
$9.83M Buy
234,624
+594
+0.3% +$23K 3.16% 7
2021
Q1
$7.89M Buy
234,030
+7,642
+3% +$272K 2.9% 10
2020
Q4
$7.91M Buy
226,388
+9,200
+4% +$318K 2.95% 9
2020
Q3
$7.54M Buy
217,188
+6,632
+3% +$221K 3.18% 9
2020
Q2
$6.89M Buy
210,556
+3,990
+2% +$127K 3.12% 7
2020
Q1
$6.22M Buy
+206,566
New +$6.15M 4.44% 7

Other funds holding NVO

Bar Harbor Trust Services's NVO Position: Q2 2022 in Review

Bar Harbor Trust Services sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 231,134 shares — an estimated $12.8M sold.

Bar Harbor Trust Services first reported a position in NVO in Q1 2020 and held it in 9 quarters. The position peaked at $12.9M in Q4 2021. 934 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

  • Bar Harbor Trust Services reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
  • Bar Harbor Trust Services sold 231,134 Novo Nordisk shares in Q2 2022, an estimated $12.8M.
  • Bar Harbor Trust Services first reported a position in Novo Nordisk in Q1 2020 and held it in 9 quarters.
  • Bar Harbor Trust Services's Novo Nordisk position peaked at $12.9M in Q4 2021.
  • 934 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on Bar Harbor Trust Services's 13F filing for Q2 2022.